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The disinfection of potable waters has been a
major public health initiative of the past cen-
tury, drastically reducing waterborne diseases.
However, epidemiologic studies found associ-
ations between elevated levels of disinfection
by-products (DBPs) and increased risks of
bladder, rectal, and/or colon cancers (1–6)
and adverse pregnancy outcomes (7–10). A
major criticism of these studies is the inade-
quate characterization of exposure (11). Many
different indices are used to assign exposure,
including surface water versus groundwater
source; chloraminated versus chlorinated
source; total or individual trihalomethanes
(THMs); and haloacetic acid (HAA) concen-
trations. Generally, average DBP levels mea-
sured at the treatment plant or within the
distribution system are assigned to all resi-
dents served by that treatment plant, which
can result in DBP exposure misclassiﬁcation.
To address DBP exposure assessment
issues in epidemiologic studies, scientists
from various disciplines (e.g., chemists,
engineers, toxicologists, biostatisticians, epi-
demiologists) participated in a workshop in
Ottawa, Canada, on 7–10 May 2000. The
goals of the workshop were to develop better
approaches in exposure assessment, provide
insight on how to better interpret previously
conducted studies, and promote more
understanding among the disciplines of the
need for more effective exposure assessment
tools for epidemiologic studies.
The workshop was divided into four ses-
sions with presentations and panel discus-
sions. In this report, we review key elements
of the problems discussed at each session of
the workshop and summarize the major
findings and recommendations. The
Appendix lists the members of the panel.
Tap Water Sampling, Analysis,
and Distribution System
Modeling
The ﬁrst session was concerned with drinking
water sampling (timing, frequency, parameters
to measure), factors affecting DBP formation,
chemical analysis, and modeling of DBPs
within the distribution system. Historical data
on the occurrence of DBPs have been col-
lected mostly in response to regulatory
requirements. Consequently, the sampling
strategies have not been designed to deter-
mine exposure for studies of adverse health
effects. For example, in the United States,
DBP concentrations are required to be
reported only four times per year (quarterly
basis) at four locations in the distribution sys-
tem (three at average detention time and one
at maximum detention time), with compli-
ance based on a running annual average of
these 16 samples. Smaller utilities may sample
even less frequently.
DBP concentrations in a water distribu-
tion system can differ signiﬁcantly from con-
centrations at the point of entry from the
water treatment plant. Concentrations can
increase or decrease because of biologic and
chemical reactions within the distribution
system and because of system hydraulics. For
example, in a chlorinated system, THMs can
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The inability to accurately assess exposure has been one of the major shortcomings of epidemio-
logic studies of disinfection by-products (DBPs) in drinking water. A number of contributing fac-
tors include a) limited information on the identity, occurrence, toxicity, and pharmacokinetics of
the many DBPs that can be formed from chlorine, chloramine, ozone, and chlorine dioxide disin-
fection; b) the complex chemical interrelationships between DBPs and other parameters within a
municipal water distribution system; and c) difﬁculties obtaining accurate and reliable informa-
tion on personal activity and water consumption patterns. In May 2000, an international work-
shop was held to bring together various disciplines to develop better approaches for measuring
DBP exposure for epidemiologic studies. The workshop reached consensus about the clear need
to involve relevant disciplines (e.g., chemists, engineers, toxicologists, biostatisticians and epi-
demiologists) as partners in developing epidemiologic studies of DBPs in drinking water. The
workshop concluded that greater collaboration of epidemiologists with water utilities and regula-
tors should be encouraged in order to make regulatory monitoring data more useful for epidemio-
logic studies. Similarly, exposure classification categories in epidemiologic studies should be
chosen to make results useful for regulatory or policy decision making. Key words: disinfection by-
products, epidemiologic methods, exposure assessment, haloacetic acids, trihalomethanes.
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distance from the plant, whereas some HAAs
(e.g., dichloroacetic acid) are biodegraded at
the end of a distribution system (locations
with maximum retention time), where there
is little or no chlorine residual. Other DBPs
(e.g., chloral hydrate, haloacetonitriles,
haloketones) may degrade in a distribution
system maintained at an alkaline pH (e.g.,
~pH 8–9) because of base-catalyzed hydroly-
sis. In fact, the hydrolysis by-products of
some of these DBPs are other DBPs (e.g.,
chloral hydrate or 1,1,1-trichloropropanone
are hydrolyzed to chloroform, one of the
THMs). Hence, an individual’s exposure
from tap water may vary spatially (e.g.,
workplace vs. home) and temporally
(depending on variations in water quality
and/or treatment from season to season, day
to day, and throughout the day) (12).
Current water utility sampling protocols
for monitoring DBPs within the distribution
system are generally inadequate for classifying
an individual’s exposure in reproductive/
developmental epidemiologic studies. A grab
sample represents only the DBP concentra-
tions at that location and time. Fetal organ
development occurs very early in gestation
and over a relatively short time interval.
During this period of organogenesis, the fetus
is particularly sensitive to environmental
exposures (13). Fetal growth mostly occurs
during the last trimester of gestation.
Therefore, the exposure during the time
period (window) relevant to a specific out-
come must be accurately characterized. Even
quarterly sampling may not be suitable for
reproductive studies because the samples may
be taken as much as 5 months apart, and
hence peak occurrences could be missed.
Although the critical exposure window, if
any, for DBPs remains unknown, the work-
shop recommended at least monthly sampling
of several representative locations within the
distribution system for exposure assessment in
human reproductive/developmental studies.
When data are not available for the time win-
dow of interest, one approach for reproduc-
tive studies has been to estimate DBP levels
by sampling one year later (9). However, this
may be problematic if there have been signiﬁ-
cant year-to-year variations in hydrology, cli-
mate, water quality, DBP precursor levels,
treatment practices, and/or distribution-sys-
tem hydraulics. The extent of the temporal
differences will be system speciﬁc. A compari-
son of routinely collected parameters, such as
total organic carbon (TOC), bromide, chlo-
rine dose, chlorine residual, temperature, pH,
and hydraulic parameters, from the two time
periods could be used to assess the validity of
reliance on the subsequent sampling period.
Quarterly monitoring was considered
adequate for long-term chronic health effect
studies (such as cancer). However, because
of the long latency periods (decades) for can-
cer, historical exposure data are required. For
cancer studies, the challenge is in predicting
historical DBP exposure, especially if the
etiologically relevant time period is prior to
the implementation of current DBP moni-
toring programs and there have been signiﬁ-
cant changes in treatment practices (e.g., to
meet current DBP regulations). Moreover,
measures of DBP precursors (TOC, bro-
mide) have been collected only in recent
years. Historical DBP predictions may need
to depend on collecting other water quality
parameters (e.g., color, chloride) to estimate
historical DBP precursor loadings.
Overall, a utility-specific (intrasystem)
monitoring plan is needed to account for
the degree of spatial and temporal variation
in planning an epidemiologic study (14).
Perhaps even more important, a determina-
tion must be made as to how much
intrasystem variation in DBP concentra-
tions is tolerable in the context of an epi-
demiologic study. Accurate assessment of
DBP levels in an individual’s water supply
is important in calculating exposure
because these levels are the basis for actual
exposure due to water-use activities and
consumption patterns (7,15,16). However,
the degree of accuracy necessary for such
studies has yet to be determined.
The recommended ideal set of parame-
ters to adequately characterize DBP exposure
is shown in Table 1. However, in most stud-
ies, it will be difﬁcult or impossible to obtain
data for all the parameters listed in this table.
Therefore, researchers will need to prioritize
which parameters to obtain to significantly
improve exposure assessment for their study.
The estimated costs for the suite of four
THMs and nine HAAs is $400 (U.S.) per
sample. The suggested level of precision for
concentration of individual DBPs at the tap
should be within 10–20%. Strict protocols
must be followed to preserve the integrity of
the sample and ensure that the DBP levels at
the time of the analysis accurately reﬂect the
levels at the time of sample collection. This is
achieved by quenching the disinfectant resid-
ual and adjusting the pH of the sample.
Analyses of polar DBPs, like the HAAs, have
required expensive, complex, and time-con-
suming (about 20 samples/24 hr) preparative
analytical procedures. Some promising new
techniques such as electrospray ionization–
mass spectrometry (ESI–MS) alone (17) or in
combination with high-field asymmetric
waveform ion mobility spectrometry
(ESI–FAIMS–MS) (18,19) offer prospects
for substantial improvements for polar DBPs
like that seen with HAAs. ESI–MS and ESI–
FAIMS–MS can reduce the time required for
analysis to less than 5 min/sample.
The focus of most of the data collection
and research has been on the THMs and, to a
lesser extent, on the HAAs. However, hun-
dreds of other DBPs have been identified
(20,21) in treated drinking water. Very little
data exist on the occurrence or toxicity of
these DBPs; however, new efforts are address-
ing certain priority DBPs (21–23). The work-
shop participants recommended specific
DBPs to consider in future studies based on
toxicologic considerations (Table 2).
Water quality simulation models can be
used to estimate DBP levels at speciﬁc resi-
dences in a water distribution system. Most
of the predictive equations for THM and
HAA formation are empirical in nature,
derived from multiple linear regression analy-
sis of laboratory chlorination experiments
conducted under controlled experimental
conditions (24,25). Although these equations
are typically based on experiments conducted
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Table 1. Ideala set of tap water quality parameters
to collect for each water treatment plant.
Chemical parameters
Total organic carbon
Ultraviolet absorbance at 254 nm
Speciﬁc ultraviolet absorbance 
Bromide
Four THMsb
Nine HAAsc
Total organic halogen
Total organic chlorine
Total organic bromine
At least one from each class of priority DBPs
(see Table 2)
Chlorine dose, demand, residual
Physical parameters
Conductivityd
Temperature
pH
Treatment practices
Primary and residual disinfection agentse
Filtration type
Types of coagulants
Advanced processes (e.g., granular activated 
carbon, membranes)
Others
Some measure of residence time in distribution
system (e.g., water age)
Storage facilities in the distribution system
Water demand patterns of consumers
Hydraulic ﬂow in distribution system
Use of EPANET software
Analytical methods used to measure various
parametersf
Time, date, and location of samples within 
distribution system
aThese recommendations are aspirational rather than
mandatory. The resources or even feasibility to determine
every item in this listing is not likely to be available for any
one study, but each recommended parameter offers value
added to the challenge of DBP exposure assessment.
bChloroform, bromodichloromethane, dibromochloro-
methane, bromoform. cChloroacetic acid, dichloroacetic
acid, trichloroacetic acid, bromoacetic acid, dibro-
moacetic acid, tribromoacetic acid, bromochloroacetic
acid, dibromochloroacetic acid, and bromodichloroacetic
acid. dAs tracer of source waters in blended distribution
systems. eIncludes doses and points of application.
fDetection limit, dechlorination agent, if any.on a wide range of waters, they yield a central
tendency prediction that may not character-
ize variability in exposure at speciﬁc sites. In
some cases, a central tendency model can be
modiﬁed to improve the predictive capacity
for site-specific uses. In other cases, a new
model needs to be developed. However, link-
age of predictive equations for DBP forma-
tion to epidemiologic studies is not a trivial
endeavor. Important considerations are how
well the models predict DBP concentrations
at a set of predetermined node points such
as those used in hydraulic performance
models, and how well those node points
represent hydraulic and water-quality condi-
tions at individual residences. Evaluation of
the predictive equations for THMs and
HAAs in a simulated pipe environment has
shown that the rate of THM formation
from point-of-entry kinetic tests performed
in clean bottles can be signiﬁcantly different
than the rate in an actual pipe system (26).
This effect was not as pronounced for
HAAs. A ﬁrst-order DBP saturation growth
model applied to a water distribution
system by linking it with a hydraulic model
found the results disappointing for predicting
both THMs and HAAs (27).
The panel identified a number of
research needs for sampling, analysis, and
modeling of DBPs (Table 3). Evidence is
mounting that knowledge about exposure
to specific DBPs within a given class (e.g.,
brominated vs. total THMs) is likely to be
as important or more important than total
DBP class exposure levels. Improved tech-
niques and standardization of methods are
needed for water sample collection and
measuring residence time in the system
(e.g., “water age”). Effective collaboration is
required among analytical chemists, water
quality specialists, and epidemiologists to
develop monitoring programs that will
achieve the exposure assessment objectives.
Surrogate Measures 
of Exposure
The discussion in this session focused on fea-
tures of epidemiologic study design and
questionnaire content (and other surrogate
measures of exposure) that affect the quality
of DBP exposure assessment. Water utility
personnel and other professionals (e.g.,
chemists, engineers, and toxicologists)
should be involved as collaborators early in
the design of epidemiologic studies.
Strategies for measuring DBP exposure will
differ among studies of cancer and reproduc-
tive outcomes. Cancer studies present
unique challenges by requiring estimates of
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Table 2. Other speciﬁc disinfection by-products to
be considered for future studies based on toxico-
logic considerations.
MX and analogs: 
3-Chloro-4-(bromochloromethyl)-5-hydroxy-2(5H)-
furanone (BMX-1)
3-Chloro-4-(dibromomethyl)-5-hydroxy-2(5H)-
furanone (BMX-2)
3-Bromo-4-(dibromomethyl)-5-hydroxy-2(5H)-
furanone (BMX-3)
3-Chloro-4-(dichloromethyl)-5-hydroxy-2(5H)-
furanone (MX) 
Haloacids
3,3-Dichloropropenoic acid
Halomethanes
Bromochloroiodomethane
Dibromoiodomethane
Dichloroiodomethane
Halonitromethanes
Dibromonitromethane
Haloacetonitriles
Bromochloroacetonitrile
Dibromoacetonitrile
Haloketones
1,3-Dichloropropanone
1,1,3-Trichloropropanone
1,1,3,3-Tetrachloropropanone
1,1-Dibromopropanone
1,1,3,3-Tetrabromopropanone
Haloaldehydes
Dichloroacetaldehyde
Bromochloroacetaldehyde
Haloacetates
Bromochloromethyl acetate
Haloamides
2,2-Dichloroacetamide 
Aldehydes
2-Hexenal 
Cyanoformaldehyde
Table 3. Tap water sampling, analysis and distribution modeling: research needs.
More and better data on occurrence and toxicity for
Chlorine DBPs—both halogenated and nonhalogenated (e.g., aldehydes)
Ozone DBPs
Chlorine dioxide DBPs
Chloramine DBPs
Exposure reconstruction by exploiting site-speciﬁc correlations among
Trihalomethanes, haloacetic acids, and other DBPs
Brominated species and bromide
Potential surrogate measure for bromide (e.g., chloride)
DBPs and other measures (chlorine demand, speciﬁc ultraviolet absorbance)
New identiﬁcations of
Polar and nonvolatile DBPs
Thermally labile DBPs
Higher-molecular-weight DBPs
Standards and standardized analytical methods for DBPs that are not routinely analyzed
Models to predict historic DBP formation in treatment plants and distribution systems: factors that should be 
considered in model development are the capability to
Represent variability in raw water sources
Utilize historically available water quality parameters
Estimate speciﬁc DBPs
Incorporate changes in treatment practices over time
Measure residence time by location in distribution system better than has been possible to date
Deal with the reality that some historic DBP monitoring data were collected without the use of dechlorination 
agents
Deal with improvements in analytical detection limits over time
Kinetic models interfaced with hydraulic network models to describe DBP behavior: factors that should be 
considered in model development are
Parameters need to be site speciﬁc
Models must be calibrated and validated and
Represent sufﬁcient time frame for exposure analysis
Address diurnal variations in water demands and pumping/distribution practices
Address blending issues
Surface and groundwater sources
Water from different treatment plants
Water from different systems (wholesaler vs. retailer)
Improved methods for water sample collection
To arrest (quench) reactions to form additional DBPs
Choice of dechlorination (quenching) agent and preservation pHa
Improved methods for determining chlorine dose in treatment plant
Considering that chlorine dose can vary signiﬁcantly during the course of the dayb 
Identiﬁcation of chemical reactions occurring in hot water tanks and during boiling of water
Considering that increases in temperature and other storage conditions affect formation and stability of DBPs 
Evaluation of the effectiveness of surrogates for improving DBP data exposure estimates
Ultraviolet absorbancec
Conductivityd
Adaption of monitoring protocols to collect data more useful for future epidemiologic studies
aSome DBPs, if not properly preserved, will degrade during sample storage; in some cases, the degradation by-products
are other DBPs, such as the trihalomethanes. bSunlight-catalyzed destruction of chlorine in open treatment basins
requires adjustments in the dose during the daylight hours. cIndicator of reactivity of total organic carbon to form DBPs.
dUsed as a tracer of source waters in blended distribution systems. exposure data from the distant past usually
without relevant exposure measurements.
Most of the discussion at the workshop was
related to exposure assessment for reproduc-
tive studies, which focus on relatively recent
exposures. Table 4 is a summary of the
panel’s recommendations on minimum
exposure information to collect for repro-
ductive outcome studies.
One promising study design is for the
investigator to select study sites that maxi-
mize contrasts in potential DBP exposure
among populations while minimizing vari-
ability of DBP exposures within sites. Sites
that are consistently in the low or high tails
of the distribution for the DBPs of interest,
and that have low temporal and spatial varia-
tion within their distribution systems, offer
the best prospects, provided the population
base is sufficiently large for the health out-
comes under study. Within a site chosen for
its DBP level, variations in exposure will
occur, particularly if individuals do not live
and work in the same area or use filters or
bottled water. When comparing different
geographical areas with differing DBPs,
however, investigators must understand that
underlying differences among the sites could
bias results (e.g., access to prenatal screening
or abortion clinics [in studies of reproductive
outcomes], other environmental exposures,
lifestyle factors, and risk-taking behaviors).
When analyzing the data, investigators
should select exposure categories that, when
possible, are relevant to regulatory and pol-
icy decisions. For example, researchers could
use cut-points for assigning exposure cate-
gories that include current and proposed
maximum contaminant levels.
The current state of knowledge is suffi-
ciently limited that some studies are still
needed to generate viable hypotheses about
DBPs (hazard identiﬁcation), whereas other
studies are needed to test hypotheses (e.g.,
whether brominated DBPs are a greater
health risk than chlorinated DBPs). In
exploratory types of studies, researchers
should avoid restricting data collection to
only one exposure window of interest.
Deferring this restriction to the analysis
phase of the study will allow greater ﬂexibil-
ity in exploring several hypotheses regarding
the critical exposure period for the health
outcomes under study.
Ecologic study designs (where informa-
tion on the exposure and disease is an overall
index available for a group of people rather
than for the individual) may be attractive for
interesting natural experiments such as
before-and-after studies evaluating changes
in treatment practices over time in the same
geographical area. For the ecologic design,
problems with selection bias, recall errors,
and missing data on individual exposure or
outcome may be less important. Of course,
analytic study designs will ultimately be
needed to test hypotheses that have been
generated by effective ecologic study designs.
The panel identified a number of areas
needing further research (Table 5), such as
developing, testing, standardizing, and vali-
dating questions on water consumption and
use patterns. The common view held by
members of the panel is that our estimates of
recent DBP personal exposure are likely in
error by well over a factor of 2 (i.e., quantita-
tive estimates of individual DBP exposure
from all routes likely range from 0.5 to 2
times the true value for any individual).
Further research is needed to determine how
much exposure misclassification is tolerable
and what level of accuracy is needed to
achieve that tolerable level. Finely character-
izing answers to questions on activity pat-
terns may provide more detailed information,
but the value of incremental detail needs to
be judged according to its ability to reduce
errors in exposure misclassification.
Resources may be better spent increasing the
number of tap water samples collected.
Future epidemiologic research needs to
reﬂect the inevitable diversity of DBP expo-
sures and emerging insights from toxicology
studies about DBP exposure routes, meta-
bolic pathways, and toxicity mechanisms.
Biomarkers of Exposure
Biomarkers have been classified into bio-
markers of exposure, biomarkers of effect,
and biomarkers of susceptibility. The pri-
mary concern of this session was biomarkers
of exposure, but some insights about the
utility for exposure assessment of biomarkers
of effect and of susceptibility also emerged.
Optimally, DBP biomarkers should be
sensitive and specific to the exposure of
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Table 4. Recommended information to collect by questionnaire for recent disinfectant by-product
exposure assessment (relevant to reproductive outcome studies).
Water consumption characteristics and water use activities diary for critical exposure period
Type of activity (e.g., showering, bathing, operation of dishwashers and washing machines, use of swimming 
pools and hot tubs)
Source of water 
Tap or bottled
Home or other location
Ground or surface (river or lake)
Hot or cold tap or boiled water
Supplier (e.g., name of utility, private well)
Volume consumed (ingestion), duration of shower/bath (inhalation or dermal exposure) 
Water temperature
Air circulation level (e.g., in bathroom)
Factors potentially modifying concentration
Water ﬁltersa 
Boiling of waterb 
Use of bottled waterc 
Allowing water to stand (stored vs. directly from tap)
Time of day, season
Other sources of exposure
Foods and beveragesd
Pharmaceuticals (direct agents and metabolites)
Occupation and full range of workplace activities
aType, location, maintenance schedule. bDo not assume that all DBPs are volatilized off; moreover, some may form dur-
ing the boiling process as residual chlorine reacts at an elevated temperature with DBP precursors in the water. cDo not
assume to be free of DBPs. dIncluding those prepared with tap water having disinfectant residual.
Table 5. Epidemiologic study design: research needs.
Improved methods for measuring water consumption and use patterns
Standardized questions that are
Valid and reliable (accurate recall)
Tested in different geographical areas
Development of a “gold standard” to test against
Further testing on usefulness of water meter data loggers
Strategies to accurately estimate past activities (e.g., look at differences in population activity patterns by age 
and locale)
Development of perspectives on
How much exposure misclassiﬁcation is tolerable?
What level of accuracy is needed to achieve that tolerable level?
Direction on valid means of combining exposure data based on such factors as
Diversity of individual DBPs
Metabolic pathways
Toxicity mechanisms 
Routes of exposure
New cancer studies that can exploit emerging biomarkers of susceptibility to relevant cancer sitesinterest, readily accessible, inexpensive to
measure, and technically feasible to measure;
have an elimination half-life appropriate to
the exposure window of interest; be indica-
tive of exposure duration, intensity, and pat-
tern; and be consistently and quantitatively
related to exposure.
Biomarkers of exposure can be used to
reﬁne exposure assessment (i.e., establish that
exposure has occurred with some measure of
the extent of exposure), reconstruct exposure
from all routes, evaluate effectiveness of inter-
ventions (e.g., changes in treatment practices
or regulations), identify important data gaps
for questionnaires, and identify susceptible
populations. Some work has been done in
developing biomarkers for THMs in blood
(28–30) and exhaled breath (31–33) and
HAAs in urine (33–35). The studies on
HAAs in urine (33–35) involved a cross-
sectional sampling design that precluded
evaluation of intraindividual variability and
limited the assessment of interindividual vari-
ability. Recent research from a longitudinal
exposure trial to evaluate trichloroacetic acid
(the most promising HAA biomarker) indi-
cated that both of these sources of variability
are important (36). DBP biomarker research
has developed sufficiently to discriminate
population average exposure differences, but
more research is needed to interpret individ-
ual differences in biomarker levels and to val-
idate what the measured biomarker levels
actually represent in terms of DBP exposure.
In particular, the contribution to biomarker
levels of sources other than drinking water
must be better understood. Knowledge of
DBP toxicokinetics, which continues to be
developed for HAAs and THMs (37,38), and
human physiologically based toxicokinetic
models, which will soon be available for
bromodichloromethane (39), should prove
valuable in using biomarker data to ascertain
DBP exposure.
The practicality of using biomarkers in
epidemiologic studies should be considered.
Standard methods for a biomarker such as
trichloroacetic acid in urine are very labor
intensive and susceptible to analyte loss.
Estimated costs for a study population of
2,000 couples, with two urine samples per
person and associated residential and work-
place tap water samples, would be more than
$1.5 million over a 2-year period. New
methods may substantially reduce the cost
and time required to measure biomarkers
[e.g., solid-phase microextraction followed
by fast gas chromatography with either elec-
tron capture detection or mass spectometry
can substantially reduce sample volume
requirements and analysis time for biological
samples (40)]. The emerging technology of
ESI–MS and ESI–FAIMS–MS shows early
promise for rapid analyses of HAAs (18,19),
which may eventually make such biomarkers
more feasible, although considerable method
development and validation are required.
Collecting and analyzing biomarkers at
very low concentrations require rigorous
protocols. Commercial vacutainer rubber
stoppers contain volatile compounds (e.g.,
bromoform), which can severely interfere
with accurate measurements of THMs in
blood (41). These compounds must be
removed by heating the stoppers under
vacuum prior to use. Current detection lim-
its for THMs in blood are below 1 pg/mL
(42), which is sufﬁcient to provide quantita-
tive levels of THMs in the blood of most
users of chlorine- or chloramine-treated
water. Blood samples can be stored under
refrigeration for up to 10 weeks before
analysis. Less progress has been made in
measuring HAAs in blood. Currently, HAAs
have a considerably higher detection limit in
blood (at least 1,000 times greater) and
improved detection methods are needed.
Preliminary measurements on a series of
large, differentially exposed populations
indicate that blood levels are responsive to
concentrations and species of THMs found
in household water (30). Measurements of
blood levels after exposure through specific
routes indicate that internal dose levels of
THMs increase to a much greater extent
from inhalation or dermal exposure com-
pared with dose levels from ingestion
(30,43). However, because the putative etio-
logic agent(s) in disinfected drinking water
has not yet been identified, we cannot dis-
count the role of the ingestion route or any
metabolites of the parent compounds in
causing any observed health effect.
The research needs in DBP biomarker
development are detailed in Table 6.
Possible biomarkers of susceptibility include
DBP-metabolizing enzymes that are poly-
morphically expressed in people. For exam-
ple, glutathione S-transferase theta, can
catalyze the activation of brominated THMs
to mutagenic intermediates (44,45).
Because currently unknown biomarkers
of effect or of genetic susceptibility may be
discovered in the future, investigators in
human studies should explore the possibility
of collecting and storing appropriate tissue
samples (e.g., blood, exfoliated bladder
epithelial cells, buccal epithelial cells) for
future biomarker research. The challenges in
obtaining ethics approval and informed
consent in human studies to allow for subse-
quent genetic analysis were discussed but
not resolved.
Exposure Modeling and
Uncertainty Analysis
This session focused on the impact and
interpretation of exposure misclassification,
methods and approaches to model personal
exposure to specific DBPs, and uncertainty
analysis of the parameters of these models.
A “closest-site” method has been pro-
posed and developed as a way to possibly
reduce exposure misclassiﬁcation created by
using utilitywide average exposure assess-
ment methods. However, reliance on the
proximity of a subject’s residence to the
closest utility sampling site can produce
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Table 6. Biomarkers of DBP exposure: research needs.
Better understanding of absorption, distribution, metabolism and excretion of speciﬁc DBPs and how these are 
affected by
Chemistry of compound
Route of exposure
Prior or continuous exposure
Metabolic precursors of DBPs
Information on population differences in
Biomarker production by metabolism
Biological residence time (elimination and excretion half-life)
Indicators of susceptibility (e.g., genetic markers, presence/absence of speciﬁc enzymes such as glutathione 
S-transferases)
Physiologically based toxicokinetic models for humans for the most relevant DBPs
Toxicity of DBPs and metabolites
Need to know which agents are of toxicologic concern so can focus efforts (i.e., rapid screening tests)
Markers of longer-term exposure such as DNA or protein adducts
Possible integrated surrogate measures of exposure to multiple DBPs (e.g., analogous to total organic halogen
tests on urine) 
Valid and reliable instructions for participants on biomarker sample collection 
Population baseline data on occurrence of DBPs in biologic ﬂuids/media
Identiﬁcation of other appropriate biologic media to sample (e.g., saliva, sweat)
Identiﬁcation of important biomarkers of susceptibility
Need to examine many candidate genes to see how these polymorphisms affect risk when taken into consideration 
with exposure
Collection and archiving of human tissue samples for future biomarker development needs
Protocols on collection and storage of such samples
Development of the basis to include such plans into approvals for studying human subjects exposure misclassification. The magnitude
of the error will depend on how the distrib-
ution system is configured. For example,
nearby or even adjacent residences may be
served by different segments of a distribu-
tion system, which could result in substan-
tially different DBP levels. Errors may also
occur if study subjects reside in undersam-
pled areas of the distribution system.
Misclassification of exposure can also
occur because of difficulty in recalling and
reporting drinking water activities and con-
sumption. Number preferences by subjects
in response to questions about time spent in
an activity or volume consumed may also
contribute to misclassification errors (e.g.,
rounding estimates to common increments,
such as 5 or 10 vs. 7 min of showering time).
Whether such errors matter in the context of
actual dose needs to be assessed. In a prelim-
inary study of the effect of showering on pre-
dicted dose of chloroform, two factors had a
signiﬁcant impact—time in the shower and
amount of time spent in the bathroom after
the shower (46).
Assumptions about drinking water
source also need to be veriﬁed, as illustrated
by a convenience sample of 114 women that
found 26% used bottled or filtered water,
50% worked outside the home, and 80% of
those working outside the home used the
workplace water supply as one of their
drinking water sources (47).
Some evaluation of the nature and direc-
tion of the exposure measurement error (mis-
classiﬁcation) is required, including whether
the error is similar in all study groups. For
dichotomous exposure variables, methods are
available to estimate the impact of misclassiﬁ-
cation errors that use sensitivity (probability
that someone who is truly exposed will be
classiﬁed as exposed) and speciﬁcity (proba-
bility that someone who is truly unexposed
will be classiﬁed as unexposed) (48). 
When nondifferential misclassiﬁcation is
assumed, the same values of sensitivity and
speciﬁcity apply to both cases and noncases.
This assumption may be less reasonable in
case–control studies if, for example, cases
are more likely to recall exposures (correctly
or incorrectly) than are controls. When the
exposure variable has more than two cate-
gories, nondifferential misclassification can
lead to bias away from the null value. For
example, in a case–control study, if 20% of
the observations in each exposure category
were incorrectly classified into the lowest
exposure category and all observations in
the lowest category were classiﬁed correctly,
depending on the sample size within each
category and disease status, the expected
odds ratios could be approximately one half
of what they would have been if no misclas-
siﬁcation had occurred (49).
Misclassiﬁcation measures such as sensi-
tivity and specificity should be treated as
probabilities. This will create a recognition
and quantification of the fact that, if the
expected bias (i.e., the bias on average) from
misclassification is in one direction (e.g.,
toward the null), there is always a nonzero
probability that the misclassiﬁcation in a given
study will cause that study’s results to be dis-
torted in the opposite direction (e.g., away
from the null). This probability can be appre-
ciable in some circumstances. In addition,
measures of random variability (e.g., estimated
standard errors) of estimated misclassiﬁcation
probabilities from exposure assessment valida-
tion studies need to be propagated throughout
any correction, adjustment, or sensitivity
analyses of exposure misclassiﬁcation bias in
which those estimates are employed.
The detailed personal DBP exposure
models are driven by human activities.
Information on what activities are under-
taken, when, and for how long must be col-
lected. Any exposure model developed must
account for all relevant exposure pathways
and routes of uptake. The research needs in
this area are listed in Table 7.
Conclusions
An accurate characterization of DBP expo-
sure (from all sources and routes) for all
individuals in the study population is
required for valid risk assessment of the
potentially associated adverse health effects.
The complexity of issues requires an inter-
disciplinary approach.
Current information on DBP exposures
is largely determined by monitoring results
that are driven by regulatory requirements.
Meanwhile, regulators look to epidemiologic
evidence to justify regulatory levels. Despite
this obvious interconnection, the workshop
panel found that regulatory monitoring for
DBPs was of limited value for improving
individual classification of exposure to
DBPs, particularly for acute health effects
investigations such as reproductive studies.
The value of performing new epidemiologic
studies using inadequate DBP exposure data
sources is questionable.
The workshop panel concluded that
greater collaboration with water utilities and
regulators should be encouraged for future
epidemiologic studies. Likewise, exposure
scales, categories, and contrasts analyzed in
future epidemiologic studies should be cho-
sen to make study results useful for regula-
tory or policy decision makers. For example,
if municipal water authorities are faced with
the choice between different methods for
disinfecting water from a given source, with
little or no option to change the water
source itself, they will need epidemiologic
evidence that compares different disinfec-
tion methods applied to similar source
waters. In these circumstances, studies
comparing different source waters (e.g., sur-
face water vs. groundwater) are of limited
value for making informed choices among
disinfection alternatives.
Overall, improving the quality of
individual DBP exposure assessments will
improve the quality of evidence that can be
generated through epidemiologic studies.
Achieving these improvements will require
an interdisciplinary approach to the problem.
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Table 7. Disinfectant by-product personal exposure modeling and uncertainty analysis: research needs.
Valid human exposure models
Many individual components have been evaluated; however, most models have not been evaluated when these
components are aggregated
Results of simulation models can be used to improve epidemiologic questionnaires by pinpointing the most 
important environmental and water use activities affecting DBP exposure
Methods to evaluate contribution to exposure from various sources and routes of exposure
Will vary by type of DBP (e.g., volatile vs. nonvolatile)
Currently chloroform model used, but validity for other DBPs is unknown
What is effect of home treatment devices on total DBP exposure?
How much do DBP exposures occurring outside the home contribute to total exposure?
Models to predict historical exposure from decades ago
Speciﬁc for individual DBPs
Represent variability in personal exposures, considering all relevant routes
Sensitivity and uncertainty analysis should be done to
Determine exposure to individual DBPs (e.g., brominated species) as adverse health effects are likely caused by
particular species or combinations thereof rather than total exposure to all DBPs
Identify activities that will differentiate individuals for exposures of interest versus activities that vary little 
among individuals
Exposure models for mixtures of DBPs
Better understanding of the relationship between water concentration and actual DBP uptake
Should resources be expended on collecting more and better data on personal habits or on increasing number of 
participants in study?
What is the relative contribution of tap water compared to all other possible sources of exposure to speciﬁc DBPs 
(e.g., bottled water, other beverages, and foods)?
Development of integrated exposure models with physiologically based pharmacokinetic modelsREFERENCES AND NOTES
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